We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Savient Files Citizen Petition to Block Generic Oxandrin
The item has been added to your shopping cart.
Savient Files Citizen Petition to Block Generic Oxandrin
September 23, 2005
Savient Pharmaceuticals has filed its second citizen petition with the FDA in two years to block generic versions of its anti-weight-loss drug Oxandrin.